Skip to content

The Cooper Companies, Inc. COO Other accrued liabilities

Other accrued liabilities at other companies

Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%
Free cash flow$96.4M+433%

Valuation

See full
Market cap$12.85B-25.7%
Enterprise value$15.78B-20.2%
P/E54.5×+12.8×
P/S-1.3×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Reported directly by The Cooper Companies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.

The official record: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Cooper Companies, Inc.'s other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Cooper Companies, Inc.'s other accrued liabilities?
The Cooper Companies, Inc. (COO) reported other accrued liabilities of $353.9M in Q1 2026.
How has The Cooper Companies, Inc.'s other accrued liabilities changed year-over-year?
The Cooper Companies, Inc.'s other accrued liabilities decreased by 16.5% year-over-year, from $423.8M to $353.9M.
What is the long-term trend for The Cooper Companies, Inc.'s other accrued liabilities?
Over 5 years (2020 to 2025), The Cooper Companies, Inc.'s other accrued liabilities has grown at a 9.8% compound annual growth rate (CAGR), from $266.8M to $425.4M.